Microglial alterations in human Alzheimer's disease following Aβ42 immunization.
- Published in:
- Neuropathology & Applied Neurobiology, 2011, v. 37, n. 5, p. 513, doi. 10.1111/j.1365-2990.2010.01156.x
- By:
- Publication type:
- Article
Works matching DE "ELAN Pharmaceuticals Inc."
Results: 15
1
2
Tysabri's return draws cautious optimism.
- Published in:
- American Journal of Health-System Pharmacy, 2006, v. 63, n. 15, p. 1388, doi. 10.2146/news050092
- By:
- Publication type:
- Article
3
Recent Developments in Patent Law: Decisions by the U.S. Court of Appeals for the Federal Circuit.
- Published in:
- Texas Intellectual Property Law Journal, 2004, v. 12, n. 3, p. 497
- By:
- Publication type:
- Article
4
Tysabri may make a comeback but with limited market potential.
- Published in:
- Chemistry & Industry, 2005, n. 17, p. 6
- By:
- Publication type:
- Article
5
And another suffering.
- Published in:
- Chemistry & Industry, 2005, n. 12, p. 6
- Publication type:
- Article
6
More restructuring.
- Published in:
- Chemistry & Industry, 2005, n. 8, p. 5
- By:
- Publication type:
- Article
7
Patch helps to cut back on drinking alcohol.
- Published in:
- Chemistry & Industry, 2004, n. 8, p. 5
- By:
- Publication type:
- Article
8
N-type calcium channel blockers: A call for papers.
- Published in:
- American Journal of Hospice & Palliative Medicine, 2005, v. 22, n. 2, p. 91, doi. 10.1177/104990910502200203
- By:
- Publication type:
- Article
9
CAUTION ABOUT PAIN MANAGEMENT DRUGS WITH LOOK-ALIKE AND SOUND-ALIKE NAMES.
- Published in:
- Journal of Pain & Palliative Care Pharmacotherapy, 2004, v. 18, n. 2, p. 109
- Publication type:
- Article
10
An opportunity lost.
- Published in:
- Nature, 2004, v. 430, n. 7001, p. 709, doi. 10.1038/430709b
- Publication type:
- Article
11
Doctors seek lost data on Alzheimer's vaccine.
- Published in:
- Nature, 2004, v. 430, n. 7001, p. 715, doi. 10.1038/430715a
- By:
- Publication type:
- Article
12
Harnessing the immune system to battle Alzheimer's.
- Published in:
- EMBO Reports, 2002, v. 3, n. 3, p. 207, doi. 10.1093/embo-reports/kvf061
- By:
- Publication type:
- Article
13
FDA postpones Tysabri decision.
- Published in:
- Inside MS, 2006, v. 24, n. 3, p. 32
- Publication type:
- Article
14
Tysabri suspended.
- Published in:
- Inside MS, 2005, v. 23, n. 2, p. 27
- Publication type:
- Article
15
Impact of natalizumab on patient-reported outcomes in multiple sclerosis: a longitudinal study.
- Published in:
- Health & Quality of Life Outcomes, 2012, v. 10, n. 1, p. 155, doi. 10.1186/1477-7525-10-155
- By:
- Publication type:
- Article